期刊文献+

非小细胞肺癌组织中TC-1、CyclinD1、β-catenin蛋白表达的变化及意义 被引量:3

Change of expression of TC-1,CyclinD1 and β-catenin in non-small cell lung cancer and its meaning
下载PDF
导出
摘要 目的探讨甲状腺癌相关基因1(TC-1)、细胞周期蛋白D1(CyclinD1)、β-链蛋白(β-catenin)在非小细胞肺癌组织中的表达情况及其与非小细胞肺癌(NSCLC)病理特征的相关性。分析其与Wnt/β-catenin信号通路的调控的相关性,为研究TC-1在NSCLC中的作用提供依据。方法用免疫组化方法检测TC-1、CyclinD1、β-catenin蛋白在48例NSCLC中的表达,并结合肺癌的临床病理特征进行分析。结果 TC-1、CyclinD1、β-catenin在非小细胞肺癌组织中的表达水平明显高于正常肺组织;其中TC-1在NSCLC组织中的表达与淋巴结转移和TNM分期有关;β-catenin在NSCLC组织中的表达与病理类型和组织分化程度有关。结论 NSCLC患者中TC-1、CyclinD1和β-catenin蛋白的表达均为上调趋势,其可能在肺癌的发展中发挥重要作用;TC-1可能参与Wnt/β-catenin信号通路的调控作用,这些都为NSCLC的靶向治疗提供了新的研究思路。 Objective To investigate the expression situation of thyroid cancer related gene-1 (TC-1),CyclinD1 andβ-catenin in the tissues of non-small cell lung cancer(NSCLC)and their relationship with the clinical pathologic characteristics,to analyze their relationship with the regulation of Wnt/β-catenin signal pathway to provide the basis for studying the role of TC-1 in NSCLC. Methods The expressions of TC-1,CyclinD1 and β-catenin in 48 patients with NSCLC were detected by immunohistochemical SP method and analyzed by combining the clinical pathological features.Results The expression levels of TC-1,CyclinD1 andβ-catenin in the NSCLC tissue were significantly higher than those in the normal lung tissue;in which,the expression of TC-1 in NSCLC tis-sue was associated with lymph node metastasis and TNM stages;the expression ofβ-catenin in NSCLC tissue was related with the pathological types and tissue differentiation degree.Conclusion The expressions of TC-1,CyclinD1 andβ-catenin show the up-regu-lating trend in NSCLC and may play an important role in the development of lung cancer;TC-1 may be involved in the regulation of Wnt/β-catenin signaling pathway,which provide the new research thought of the NSCLC targeted therapy.
出处 《国际检验医学杂志》 CAS 2014年第20期2723-2725,共3页 International Journal of Laboratory Medicine
关键词 非小细胞肺癌 甲状腺癌相关基因1 细胞周期蛋白D1 Β-链蛋白 non-small cell lung cancer β-catenin
  • 相关文献

参考文献11

  • 1徐新娟,丁文柏.Wnt信号转导通路与肺癌的研究近况[J].医学综述,2008,14(2):217-220. 被引量:4
  • 2Gordon MD, Nusse R. Wnt signaling : multiple pathways, multiplereceptors,and multiple transcription factors [J]. J Biol Chem,2006,281(32):22429-22433.
  • 3Yc L,Ryo R, Huang HK,et al. Loss of pinl function in the mouseUSA,2002,99(3) .1335-1340.
  • 4Polakis P. Wnt signaling and cancer[J]. Genes Dev,2000,14(1):1837-1851.
  • 5海红艳,胡雪君,侯科佐,曲秀娟,康健,刘云鹏.非小细胞肺癌组织EGFR和VEGF及Cbl表达的临床意义[J].中华肿瘤防治杂志,2010,17(3):209-212. 被引量:12
  • 6Akiri G,Cherian MM? Vijayakumar S,et al. Wnt pathway aberra-tions including autocrine Wnt activation occur at high frequency inhuman non-small-cell lung carcinoma [ J ]. Oncogene, 2009, 28(21):2163-2172.
  • 7De Melo MP,Parise JO’Peroira HC’et al. C80rf4/TC-l C thyroidcancer-1)gone expression in thyroid cancer and goiter[J], ORL JOtorhinolaryngol Relat,2007 ,69(2) : 127-130.
  • 8Wang YD, Bian GH, Lv XY? et al. TCI CC8orf4) is involved inERK1/2 pathway-regulated G( 1 )-to S-phase transition[J]. BMBRep,2008,41(10):733-738.
  • 9Jung Y, Bang S, Choi K, et al. TCI (C8orf4) enhances the Wnt/beta-catenin pathway by relieving antagonistic activity of Chibby[J]. Cancer Res, 2006 ,66(2) : 723-728.
  • 10Deiros Bronte L, Baquero-Artigao F,Garcia-Miguel MJ, et al. Pa-rapneumonic pleural effusion: an 11-year review [J]. Anales depediatria (Barcelona,Spain: 2003) ,2006 ,64(1) ;40-45.

二级参考文献29

  • 1Atkins D, Reiffen K A, Tegtmeier C L, et al. Immunoh istochem ieal detect ion of EGFR in paraffinembedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections[J]. J Histochem Cytoehem, 2004, 52(7) : 893- 901.
  • 2Mineo T C, Ambrogi V, Baldi A, et al. Prognostic impact of VEGF, CD31, CD34, and CD105 expressionand tumour vessel invasion after radical surgery for Ⅰ B--ⅡA non-small cell lung cancer[J]. J Clin Pathol, 2004, 57(6): 591-597.
  • 3Mukohara T, Kudoh S, Yamauchi S,et al. Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small cell lung cancer (NSCLC) [J]. Lung Cancer, 2003, 41(2):123-130.
  • 4Yano S, Shinohara H, Herbst R S, et al. Production of experimental malignant,pleural effusions is dependent on invasion of the pleura and expressionof vascular endothelial growth factor/vascular permeability factor byhuman lung cancer cells [J]. Am J Pathol, 2000, 157(6) :1893-1903.
  • 5Casanova M L, Iarcher F C,Casanova B,et al. Acritical Role for ras mediated, epidermal growth factor rec eptor dependent angiogenesis in mouse skin carcinogenesis [J]. Cancer Res, 2002, 62 (12) :3402-3407.
  • 6Herbst R S, Johnson D H, Mininberg E, et al. Phase Ⅰ/Ⅱ trial evaluating the antivascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1 / epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancer[J]. J Clin Oncol, 2005,23(11) :2544-2555.
  • 7Joazeiro C, Wing S, Huang H, et al. The tyrosine kinase negative regulator c-Cb1 as a RING-type, E2-dependent ubiquitin-protein ligase[J]. Science,1999, 286(5438) :309-312.
  • 8Tsuda S, Murakami M, Matsusaka N,et al. DNA darnage induced by red ram dyes orally administered to pregnant and male mice [J]. ToxioolSci,2001,61(1):92-99.
  • 9Alberg AJ,Brock MV,Samet JM.Epidemiology of lung cancer:looking to the future[J].J Clin Oncol,2005,23(14):3175-3185.
  • 10Veeman MT,Axelrod JD,Moon RT.A second canon.Functions and mechanisms of beta-catenin-indopendent Wnt signaling[J].Dev Cell,2003,5(3):367-377.

共引文献13

同被引文献51

  • 1Siegel RL,Sahar L,Portier KM,et al. Cancer death rates in US congressional districts[J]. CA Cancer J Clin,2015, 65(5): 339-344.
  • 2Choi YJ, Li X, Hydbring P,et al. The requirement for cy- elinD function in tumor maintenance[J]. Cancer Ce11,2012, 22(4) :438-451.
  • 3Masamha CP,Benbrook DM. CyclinD1 degradation is suf- ficient to induce G1 cell cycle arrest despite constitutive expression of cyclinE2 in ovarian cancer cells [J]. Cancer Res, 2009,69(16) :6565-6572.
  • 4Ogino S,Nosho K,Irahara N,et al. A cohort study of cy- clinD1 expression and prognosis in 602 colon cancer cases [J]. Clin Cancer Res, 2009,15(13) : 4431-4438.
  • 5Ishikawa T,Furihata M,Ohtsuki Y,et al. CyclinD1 over- expression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma[J]. Br J Cancer, 1998,77(1):92-97.
  • 6Li H, Xiao W, Ma J, et al. Dual high expression of STAT3 and cyclinD1 is associated with poor prognosis after cura- tive resection ofesophageal squamous cell carcinoma [J]. Int J Clin Exp Pathol, 2014,7(11) : 7989-7998.
  • 7Chung J,Noh H,Park KH,et al. Longer survival in pa- tients with breast cancer with cyclin dl over-expressionafter tumor recurrence:longer,but occupied with disease [J]. J Breast Cancer,2014,17(1):47-53.
  • 8Xu C ,Wu C ,Xia Y,et al. WT1 promotes cell proliferation in non-small cell lung cancer cell lines through up-regu- lating cyclin D1 and p-pRb in vitro and in vivo [J]. PLoS One, 2013,8(8) : e68837.
  • 9Gautschi O,Hugll B,Zieqler A,et al. CyclinD1 (CCND1) A870G gene polymorphism modulates smok ing-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) pa- tients[J]. Lung Cancer, 2006,51 (3) : 303-311.
  • 10Esposito V,Baldi A,De Luca A,et aL Cell cycle related pro- teins as prognostic parameters in radically resected non- small cell lung cancer[J]. J Clin Pathol,2005,58(7):734-739.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部